Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

Abstract

The fibroblast growth factor receptor (FGFR) family members mediate a number of important cellular processes, and are mutated or overexpressed in several forms of human cancer. Mutation of Lys650→Glu in the activation loop of the FGFR3 kinase domain causes the lethal human skeletal disorder thanatophoric dysplasia type II (TDII) and is also found in patients with multiple myeloma, bladder and cervical carcinomas. This mutation leads to constitutive activation of FGFR3. To compare the signaling activity of FGFR family members, this activating mutation was generated in FGFR1, FGFR3, and FGFR4. We show that the kinase domains of FGFR1, FGFR3, and FGFR4 containing the activation loop mutation, when targeted to the plasma membrane by a myristylation signal, can transform NIH3T3 cells and induce neurite outgrowth in PC12 cells. Phosphorylation of Shp2, PLC-γ, and MAPK was also stimulated by all three ‘TDII-like’ FGFR derivatives. Additionally, activation of Stat1 and Stat3 was observed in cells expressing the activated FGFR derivatives. Finally, we demonstrate that FGFR1, FGFR3, and FGFR4 derivatives can stimulate PI-3 kinase activity. Our comparison of these activated receptor derivatives reveals a significant overlap in the panel of effector proteins used to mediate downstream signals. This also represents the first demonstration that activation of FGFR4, in addition to FGFR1 and FGFR3, can induce cellular transformation. Moreover, our results suggest that Stat activation by FGFRs is important in their ability to act as oncogenes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 8
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Aronheim A, Engelberg D, Li N, Al-Alawi N, Schlessinger J and Karin M. . 1994 Cell 78: 949–961.

  • Basilico C and Moscatelli D. . 1992 Adv. Cancer Res. 59: 115–165.

  • Besser D, Bromberg JF, Darnell JE and Hanafusa H. . 1999 Mol. Cell. Biol. 19: 1401–1409.

  • Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell JE. . 1999 Cell 98: 295–303.

  • Burke D, Wilkes D, Blundell TL and Malcolm S. . 1998 Trends. Biochem. Sci. 23: 59–62.

  • Buss JE, Der CJ and Solski P. . 1988 Mol. Cell. Biol. 8: 3960–3963.

  • Cao X, Tay A, Guy GR and Tan YH. . 1996 Mol. Cell. Biol. 16: 1595–1603.

  • Cappellen D, De Oliverira C, Ricol D, de Medina SGD, Bourdin J, Sastre-Garau X, Chopin D, Thiery JP and Radvanyi F. . 1999 Nat. Genet. 23: 18–20.

  • Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS and Jove R. . 1999 Immunity 10: 105–115.

  • Chen C and Okayama H. . 1987 Mol. Cell. Biol. 7: 2745–2752.

  • Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM and Bergsagel PL. . 1997 Nat. Genet. 16: 260–264.

  • D'Avis PY, Robertson SC, Meyer AN, Bardwell WM, Webster MK and Donoghue DJ. . 1998 Cell Growth Diff. 9: 71–78.

  • Galvin BD, Hart KC, Meyer AN, Webster MK and Donoghue DJ. . 1996 Proc. Natl. Acad. Sci. USA 93: 7894–7899.

  • Garcia R and Jove R. . 1998 J. Biomed. Sci. 5: 79–85.

  • Goldfarb M. . 1996 Cytokine Growth Factor Rev. 7: 311–325.

  • Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS and Tweardy J. . 1998 J. Clin. Invest. 102: 1385–1392.

  • Hadari YR, Kouhara H, Lax I and Schlessinger J. . 1998 Mol. Cell. Biol. 18: 3966–3973.

  • Hart KC and Donoghue D. . 1997 Oncogene 14: 945–953.

  • Hattori Y, Odagiri H, Katoh O, Sakamoto H, Morita T, Shimotohno K, Tobinai K, Sugimura T and Terada M. . 1992 Cancer Res. 52: 3367–3371.

  • Hughes SE. . 1997 J. Histochem. Cytochem. 45: 1005–1019.

  • Ilaria RL, Hawley RG and Van Etten RA. . 1999 Blood 93: 4154–4166.

  • Jaye M, Schlessinger J and Dionne CA. . 1992 Biochim. Biophys. Acta 1135: 185–199.

  • Johnson DE and Williams LT. . 1993 Adv. Cancer Res. 60: 1–41.

  • Kanai M, Goke M, Tsunekawa S and Podolsky DK. . 1997 J. Biol.. Chem. 272: 6621–6628.

  • Kirito K, Uchida M, Takatoku M, Nakajima K, Hirano T, Miura Y and Komatsu N. . 1998 Blood 92: 462–471.

  • Klint P, Kanda S and Claesson-Welsh L. . 1995 J. Biol. Chem. 270: 23337–23344.

  • Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I and Schlessinger J. . 1997 Cell 89: 693–702.

  • Kouhara H, Kurebayashi S, Hashimoto K, Kasayama S, Koga M, Kishimoto T and Sato B. . 1995 Oncogene 10: 2315–2322.

  • LaVallee TM, Prudovsky IA, McMahon GA, Hu X and Maciag T. . 1998 J. Cell Biol. 141: 1647–1658.

  • Landgren E, Klint P, Yokote K and Claesson-Welsh L. . 1998 Oncogene 17: 283–291.

  • Legeai-Mallet L, Benoist-Lasselin C, Delezoide AL, Munnich A and Bonaventure J. . 1998 J. Biol. Chem. 273: 13007–13014.

  • Li C, Chen L, Iwata T, Kitagawa M, Fu X-Y and Deng C-X. . 1999 Hum. Mol. Genet. 8: 35–44.

  • Lin HY, Xu JS, Ischenko I, Ornitz DM, Halegoua S and Hayman MJ. . 1998 Mol Cell. Biol. 18: 3762–3770.

  • Lin HY, Xu JS, Ornitz DM, Halegoua S and Hayman MJ. . 1996 J. Neurosci. 16: 4579–4587.

  • Lorenzi MV, Horii Y, Yamanaka R, Sakaguchi K and Miki T. . 1996 Proc. Natl. Acad. Sci. USA 93: 8956–8961.

  • Martin GR. . 1998 Genes Dev. 12: 1571–1586.

  • Mohammadi M, Dionne CA, Li W, Li N, Spivak T, Honegger AM, Jaye M and Schlessinger J. . 1992 Nature 358: 681–684.

  • Mohammadi M, Honegger AM, Rotin D, Fischer R, Bellot F, Li W, Dionne CA, Jaye M, Rubinstein M and Schlessinger J. . 1991 Mol. Cell. Biol. 11: 5068–5078.

  • Mohammadi M, Schlessinger M and Hubbard SR. . 1996 Cell 86: 577–587.

  • Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, Wang D, Hoffmeyer A, Van Deursen J, Sangster MY, Bunting KD, Grosveld GC and Ihle JN. . 1999 Immunity 10: 249–259.

  • Naski MC, Wang Q, Xu J and Ornitz DM. . 1996 Nat. Genet. 13: 233–237.

  • Neilson KM and Friesel RE. . 1995 J. Biol. Chem. 270: 26037–26040.

  • Neilson KM and Friesel RE. . 1996 J. Biol. Chem. 271: 25049–25057.

  • Olson DC, Deng C and Hanahan D. . 1998 Cell Growth Diff. 9: 557–564.

  • Partanen J, Makela RP, Eerola E, Korhonen J, Hirvonen H, Claesson-Welsh L and Alitalo K. . 1991 EMBO J. 10: 1347–1354.

  • Perkins LA, Johnson MR, Melnick MB and Perrimon N. . 1996 Dev. Biol. 180: 63–81.

  • Popovici C, Adelaide J, Ollendorff V, Chaffaner C, Guasch G, Jacrot M, Leroux D, Birnbaum D and Pebusque MJ. . 1998 Proc. Natl. Acad. Sci. USA 95: 5712–5717.

  • Popovici C, Zhang B, Gregoire MJ, Jonveaux P, Lafage-Pochitaloff M, Birnbaum D and Pebusque MJ. . 1999 Blood 93: 1381–1389.

  • Raffioni S, Thomas D, Foehr ED, Thompson LM and Bradshaw RA. . 1999 Proc. Natl. Acad. Sci. USA 96: 7178–7183.

  • Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald DH, Aguiar RC, Goncalves C, Hernandez JM, Jennings BA, Goldman JM and Cross NCP. . 1998 Blood 92: 1735–1742.

  • Richelda R, Ronchetti D, Baldini L, Cro L, Viggiano L, Marzella R, Rocchi M, Otsuki T, Lombardi L, Maiolo AT and Neri A. . 1997 Blood 90: 4062–4070.

  • Robertson SC, Meyer AN, Hart KC, Galvin BD, Webster MK and Donoghue DJ. . 1998 Proc. Natl. Acad. Sci. USA 95: 4567–4572.

  • Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D and Basilico C. . 1999 Genes Dev. 13: 1361–1366.

  • Smedley D, Hamoudi R, Clark J, Warren W, Abdul-Rauf M, Somers G, Venter D, Fagan K, Cooper C and Shipley J. . 1998 Hum. Mol. Genet. 7: 637–642.

  • Spivak-Kroizman T, Mohammadi M, Hu P, Jaye M, Schlessinger J and Lax I. . 1994 J. Biol. Chem. 269: 14419–14423.

  • Stark KL, McMahon JA and McMahon AP. . 1991 Development 113: 641–651.

  • Su W, Kitagawa M, Xue N, Xie B, Garofalo S, Cho J, Deng C, Horton WA and Fu XY. . 1997 Nature 386: 288–292.

  • Szebenyi G and Fallon JF. . 1999 Int. Rev. Cytol. 185: 45–106.

  • Tavormina PL, Bellus GA, Webster MK, Barnshad MJ, Fraley AE, McIntosh I, Szabo J, Jiang W, Jabs EW, Wilcox WR, Wasmuth JJ, Donoghue DJ, Thompson LM and Francomano CA. . 1999 Am. J. Hum. Genet. 64: 722–731.

  • Tavormina PL, Shiang R, Thompson LM, Zhu Y-Z, Wilkin DJ, Lachman RS and Wilcox WR. . 1995 Nat. Genet. 9: 321–328.

  • Vainikka S, Joukov V, Klint P and Alitalo K. . 1996 J. Biol. Chem. 271: 1270–1273.

  • Vainikka S, Joukov V, Wennstrom S, Bergman M, Pelicci PG and Alitalo K. . 1994 J. Biol. Chem. 269: 18320–18326.

  • Van Leeuwen F and Nusse R. . 1995 Semin. Cancer Biol. 6: 127–133.

  • Wang JK, Gao G and Goldfarb M. . 1994 Mol. Cell. Biol. 14: 181–188.

  • Webster MK and Donoghue DJ. . 1996 EMBO J. 15: 520–527.

  • Webster MK and Donoghue DJ. . 1997a Mol. Cell. Biol. 17: 5739–5747.

  • Webster MK and Donoghue DJ. . 1997b Trends Genet. 13: 178–182.

  • Webster MK and Donoghue DJ. . 1998 Gene Ther. Mol. Biol. 1: 365–379.

  • Webster MK, D'Avis PY, Robertson SC and Donoghue DJ. . 1996 Mol. Cell. Biol. 16: 4081–4087.

  • Wilkie AOM, Morriss-Kay GM, Jones EY and Heath JK. . 1995 Curr. Biol. 5: 500–507.

  • Wright JA and Huang A. . 1996 Histol. Histopathol. 11: 521–536.

  • Wright JA, Turley EA and Greenberg AH. . 1993 Crit. Rev. Oncogen. 4: 473–492.

  • Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman M, Hudson TJ and Fletcher JA. . 1998 Nat. Gen. 18: 84–87.

  • Yoshimura N, Sano H, Hashiramoto A, Yamada R, Nakajima H, Kondo M and Oka T. . 1998 Clin. Immunol. Immunopathol. 89: 28–34.

  • Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J and Jove R. . 1995 Science 269: 81–83.

  • Zhan X, Plourde C, Hu X, Friesel R and Maciag T. . 1994 J. Biol Chem. 269: 20221–20224.

  • Zong C, Yan R, August A, Darnell JE and Hanafusa H. . 1996 EMBO J. 15: 4515–4525.

  • Zong CS, Zeng L, Jiang Y, Sadowski HB and Wang LH. . 1998 J. Biol. Chem. 273: 28065–28072.

Download references

Acknowledgements

This work was supported by Public Health Service grant NIH/NIDCR RO1 DE12581. We thank Jill Meisenhelder, Pam Maher, and Kari Alitalo for providing reagents, Pedro Ramos and Melanie Webster for assistance in generating constructs, Michael David and Leon Su for advice and discussions regarding Stat experiments, and Laura Castrejon for editorial assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hart, K., Robertson, S., Kanemitsu, M. et al. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. Oncogene 19, 3309–3320 (2000). https://doi.org/10.1038/sj.onc.1203650

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203650

Keywords

This article is cited by

Search

Quick links